Cargando…

Assessment of the National Test Strategy on the Development of the COVID-19 Pandemic in Denmark

During the COVID-19 pandemic, Denmark has pursued a mass testing strategy culminating in the testing of 12.167 individuals per 100,000 inhabitants per day during the spring of 2021. The strategy included free access to COVID-19 testing, and since 2021, compulsory documentation for negative tests or...

Descripción completa

Detalles Bibliográficos
Autores principales: Busk, Peter Kamp, Kristiansen, Thomas Birk, Engsig-Karup, Allan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9620886/
https://www.ncbi.nlm.nih.gov/pubmed/36417215
http://dx.doi.org/10.3390/epidemiologia2040037
_version_ 1784821416145715200
author Busk, Peter Kamp
Kristiansen, Thomas Birk
Engsig-Karup, Allan
author_facet Busk, Peter Kamp
Kristiansen, Thomas Birk
Engsig-Karup, Allan
author_sort Busk, Peter Kamp
collection PubMed
description During the COVID-19 pandemic, Denmark has pursued a mass testing strategy culminating in the testing of 12.167 individuals per 100,000 inhabitants per day during the spring of 2021. The strategy included free access to COVID-19 testing, and since 2021, compulsory documentation for negative tests or vaccination has been required for access to workplace, educational institutions, restaurants, and many other places. Testing and subsequent isolation if testing was positive were voluntary. The present study provides an analysis of whether testing frequency in Denmark showed any correlation to hospitalizations throughout the relevant stages of the pandemic. Mass testing was found not to correlate significantly with the number of hospitalizations during the pandemic. Interestingly, during the highest level of testing in spring 2021 the fraction of positive tests increased slightly; thus, the Danish mass testing strategy, at its best, failed to reduce the prevalence of COVID-19. Furthermore, the relationship between positives in antigen testing and in rt-PCR testing indicated that many patients were not tested early in their infection when the risk of transmission was at the highest. In conclusion, the Danish mass testing strategy for COVID-19 does not appear to have a detectable correlation to the number of hospitalizations due to COVID-19.
format Online
Article
Text
id pubmed-9620886
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-96208862022-11-18 Assessment of the National Test Strategy on the Development of the COVID-19 Pandemic in Denmark Busk, Peter Kamp Kristiansen, Thomas Birk Engsig-Karup, Allan Epidemiologia (Basel) Article During the COVID-19 pandemic, Denmark has pursued a mass testing strategy culminating in the testing of 12.167 individuals per 100,000 inhabitants per day during the spring of 2021. The strategy included free access to COVID-19 testing, and since 2021, compulsory documentation for negative tests or vaccination has been required for access to workplace, educational institutions, restaurants, and many other places. Testing and subsequent isolation if testing was positive were voluntary. The present study provides an analysis of whether testing frequency in Denmark showed any correlation to hospitalizations throughout the relevant stages of the pandemic. Mass testing was found not to correlate significantly with the number of hospitalizations during the pandemic. Interestingly, during the highest level of testing in spring 2021 the fraction of positive tests increased slightly; thus, the Danish mass testing strategy, at its best, failed to reduce the prevalence of COVID-19. Furthermore, the relationship between positives in antigen testing and in rt-PCR testing indicated that many patients were not tested early in their infection when the risk of transmission was at the highest. In conclusion, the Danish mass testing strategy for COVID-19 does not appear to have a detectable correlation to the number of hospitalizations due to COVID-19. MDPI 2021-11-05 /pmc/articles/PMC9620886/ /pubmed/36417215 http://dx.doi.org/10.3390/epidemiologia2040037 Text en © 2021 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Busk, Peter Kamp
Kristiansen, Thomas Birk
Engsig-Karup, Allan
Assessment of the National Test Strategy on the Development of the COVID-19 Pandemic in Denmark
title Assessment of the National Test Strategy on the Development of the COVID-19 Pandemic in Denmark
title_full Assessment of the National Test Strategy on the Development of the COVID-19 Pandemic in Denmark
title_fullStr Assessment of the National Test Strategy on the Development of the COVID-19 Pandemic in Denmark
title_full_unstemmed Assessment of the National Test Strategy on the Development of the COVID-19 Pandemic in Denmark
title_short Assessment of the National Test Strategy on the Development of the COVID-19 Pandemic in Denmark
title_sort assessment of the national test strategy on the development of the covid-19 pandemic in denmark
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9620886/
https://www.ncbi.nlm.nih.gov/pubmed/36417215
http://dx.doi.org/10.3390/epidemiologia2040037
work_keys_str_mv AT buskpeterkamp assessmentofthenationalteststrategyonthedevelopmentofthecovid19pandemicindenmark
AT kristiansenthomasbirk assessmentofthenationalteststrategyonthedevelopmentofthecovid19pandemicindenmark
AT engsigkarupallan assessmentofthenationalteststrategyonthedevelopmentofthecovid19pandemicindenmark